Biocause Pharma(SZ:000627) Zheng Quan Zhi Xing·2025-08-08 15:17Core Viewpoint - The company is actively seeking to collect voting rights from all A-share shareholders for the upcoming extraordinary general meeting, where it will discuss the voluntary termination of its stock listing and amendments to its articles of association [1][2]. Group 1: Voting Rights Collection - The company’s board of directors is the organizer of the voting rights collection, aimed at gathering consent for all agenda items for the extraordinary general meeting scheduled for August 25, 2025 [1][2]. - The collection period for online voting rights is from August 14, 2025, 9:15 AM to August 21, 2025, 3:00 PM, while offline voting rights can be collected daily from August 14 to August 21, 2025, between 9:30 AM and 5:00 PM [2][5]. - The record date for confirming voting rights is set for August 13, 2025 [2]. Group 2: Reasons for Termination - The decision to voluntarily terminate the stock listing is in compliance with relevant laws and regulations, which is believed to benefit the long-term development of the company and the interests of all shareholders [1][2]. Group 3: Procedures for Participation - Shareholders can participate in the voting rights collection through an online platform or by submitting required documents to the board office [3][4]. - The necessary documents for participation include identification proof, shareholding proof, and a signed authorization letter, which must be submitted before the deadline of August 21, 2025, 5:00 PM [5][6]. - A witness lawyer will verify the validity of the submitted documents to ensure compliance with the requirements [5][6]. Group 4: Confidentiality and Compliance - The company assures that it will not misuse the collected voting rights for insider trading or market manipulation, and will maintain confidentiality regarding the voting results until the official announcement [6].